Amarin Corp Plcuk (AMRN) Inventory Average (2012 - 2026)
Amarin Corp Plcuk (AMRN) reported Inventory Average of $189.8 million for Q1 2026, up 16.58% year-over-year from $162.8 million in Q1 2025, and little changed quarter-over-quarter from $190.3 million in Q4 2025.
Amarin Corp Plcuk (AMRN) Inventory Average (2012 - 2026) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 15 years of Inventory Average data on file, last reported at $189.8 million in Q1 2026.
- Inventory Average for Q1 2026 came in at $189.8 million, up 16.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $189.8 million (up 16.58% YoY), and the FY2025 annual result was $181.0 million, down 14.77% from the prior year.
- Inventory Average was little changed at $189.8 million in Q1 2026 per AMRN's latest filing, from $190.3 million in the prior quarter.
- Over five years, Inventory Average peaked at $256.9 million in Q1 2024 and troughed at $162.8 million in Q1 2025.
- A 5-year average of $218.9 million and a median of $227.3 million in 2023 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2022 and 2025: Inventory Average climbed 19.71% in 2022, then sank 36.65% in 2025.
- A 5-year view of Inventory Average shows it stood at $228.2 million in 2022, then rose by 12.44% to $256.6 million in 2023, then dropped by 23.98% to $195.0 million in 2024, then fell by 2.42% to $190.3 million in 2025, then dropped by 0.29% to $189.8 million in 2026.
- Business Quant data shows AMRN's Inventory Average at $189.8 million in Q1 2026, $190.3 million in Q4 2025, and $178.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | 8.09 Bn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | 14.14 Bn |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 14.39 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | 5.00 Bn |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | 6.57 Bn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | 6.21 Bn |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 1.84 Bn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | 10.66 Bn |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | 2.72 Bn |
| 10 | Amarin Corp Plcuk | 6.77 Bn | 6.59 Bn | 17.77 Mn | 189.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 189.76 Mn |
| Dec 31, 2025 | 190.31 Mn |
| Sep 30, 2025 | 177.95 Mn |
| Jun 30, 2025 | 165.35 Mn |
| Mar 31, 2025 | 162.77 Mn |
| Dec 31, 2024 | 195.02 Mn |
| Sep 30, 2024 | 231.70 Mn |
| Jun 30, 2024 | 247.34 Mn |
| Mar 31, 2024 | 256.95 Mn |
| Dec 31, 2023 | 256.56 Mn |
| Sep 30, 2023 | 240.76 Mn |
| Jun 30, 2023 | 226.42 Mn |
| Mar 31, 2023 | 227.27 Mn |
| Dec 31, 2022 | 228.17 Mn |
| Sep 30, 2022 | 226.70 Mn |
| Jun 30, 2022 | 246.81 Mn |
| Mar 31, 2022 | 251.25 Mn |
| Dec 31, 2021 | 271.99 Mn |
| Sep 30, 2021 | 290.90 Mn |
| Jun 30, 2021 | 251.70 Mn |